D. Vainam, Preeclampsia ? Patholophysiology of the uterus and the pregnancy, Inserm, Institut Cochin, consulté le 14 janvier 2015, consultable à l'URL: http://cochin.inserm.fr/Departements/drc/equipe-vaiman/b-patholophysiology-of- the-uterus-and-the-pregnancy

M. A. Shembrey and A. D. Noble, An instructive case of abdominal pregnancy, J Obstet Gynaecol, vol.35, pp.220-221, 1995.

L. Gouny-doridot, Rôle du facteur de transcription STOX1 dans la physiopathologie de la pré-éclampsie : apport d'un modèle cellulaire et d'un modèle murin de transgenèse additive, pp.2013-359

H. Juch, A. Blaschitz, G. Dohr, and H. Hutter, HLA Klasse I Expression in der humanen Plazenta, Wiener Medizinische Wochenschrift, vol.12, issue.Suppl 1, 0200.
DOI : 10.1007/s10354-012-0070-7

S. E. Hiby, J. J. Walker, K. M. O-'shaughnessy, C. W. Redman, M. Carrington et al., Combinations of Maternal KIR and Fetal HLA-C Genes Influence the Risk of Preeclampsia and Reproductive Success, The Journal of Experimental Medicine, vol.25, issue.8, pp.957-965, 2004.
DOI : 10.1016/S0143-4004(03)00167-X

J. S. Hunt, M. G. Petroff, R. H. Mcintire, and C. Ober, HLA-G and immune tolerance in pregnancy, The FASEB Journal, vol.19, issue.7, pp.681-693, 2005.
DOI : 10.1096/fj.04-2078rev

J. S. Hunt, D. K. Langat, R. H. Mcintire, and P. J. Morales, The role of HLA-G in human pregnancy, Reproductive Biology and Endocrinology, vol.4, issue.Suppl 1, p.10, 2006.
DOI : 10.1186/1477-7827-4-S1-S10

C. Solier, M. Aguerre-girr, F. Lenfant, A. Campan, A. Berrebi et al., Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast, European Journal of Immunology, vol.41, issue.12, pp.3576-3586, 2002.
DOI : 10.1002/1521-4141(200212)32:12<3576::AID-IMMU3576>3.0.CO;2-M

E. W. Triche, K. K. Harland, E. H. Field, L. M. Rubenstein, and A. F. Saftlas, Maternal???fetal HLA sharing and preeclampsia: variation in effects by seminal fluid exposure in a case???control study of nulliparous women in Iowa, Journal of Reproductive Immunology, vol.101, issue.102, pp.111-119, 2014.
DOI : 10.1016/j.jri.2013.06.004

S. A. Robertson, L. R. Guerin, J. J. Bromfield, K. M. Branson, A. C. Ahlstrom et al., Seminal Fluid Drives Expansion of the CD4+CD25+ T Regulatory Cell Pool and Induces Tolerance to Paternal Alloantigens in Mice1, Biology of Reproduction, vol.80, issue.5, pp.1036-1045, 2009.
DOI : 10.1095/biolreprod.108.074658

S. A. Robertson, J. R. Prins, D. J. Sharkey, and L. M. Moldenhauer, Seminal Fluid and the Generation of Regulatory T Cells for Embryo Implantation, American Journal of Reproductive Immunology, vol.85, issue.Suppl. 1, pp.315-330, 2013.
DOI : 10.1111/aji.12107

M. J. Bilinski, J. G. Thorne, M. J. Oh, S. Leonard, C. Murrant et al., Uterine NK cells in murine pregnancy, Reproductive BioMedicine Online, vol.16, issue.2, pp.218-226, 2008.
DOI : 10.1016/S1472-6483(10)60577-9

G. E. Lash, S. C. Robson, and J. N. Bulmer, Review: Functional role of uterine natural killer (uNK) cells in human early pregnancy decidua, Placenta, vol.31, pp.87-92, 2010.
DOI : 10.1016/j.placenta.2009.12.022

F. Charalambous, A. Elia, and P. Georgiades, Decidual spiral artery remodeling during early post-implantation period in mice: Investigation of associations with decidual uNK cells and invasive trophoblast, Biochemical and Biophysical Research Communications, vol.417, issue.2, pp.847-852
DOI : 10.1016/j.bbrc.2011.12.057

G. Eastabrook, Y. Hu, V. Dadelszen, and P. , The Role of Decidual Natural Killer Cells in Normal Placentation and in the Pathogenesis of Preeclampsia, Journal of Obstetrics and Gynaecology Canada, vol.30, issue.6, pp.467-476, 2008.
DOI : 10.1016/S1701-2163(16)32862-6

P. Hoffmann, Fonctions biologiques d'EG-VEGF (Endocrine Gland-derived Vascular Endothelial Growth Factor) dans le développement placentaire ? Thèse ? Université Joseph-Fourrier ?, pp.2006-181

P. Hoffmann, J. J. Feige, and N. Alfaidy, Expression and oxygen regulation of Endocrine Gland-derived Vascular Endothelial Growth Factor/Prokineticin-1 and its receptors in human planta during early pregnancy, p.32

P. Hoffmann, J. J. Feige, and N. Alfaidy, Placental expression of EG-VEGF and its receptors PKR1 and PKR2 throughout mouse gestation, p.33
URL : https://hal.archives-ouvertes.fr/inserm-00376114

O. Genbacev, R. Joslin, C. H. Damsky, B. M. Polliotti, and S. J. Fisher, Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia., Journal of Clinical Investigation, vol.97, issue.2, pp.540-550, 1996.
DOI : 10.1172/JCI118447

F. Mondon, T. Mignot, R. Rebourcet, H. Jammes, J. Da et al., Profiling of oxygen-modulated gene expression in early human placenta by systematic sequencing of suppressive subtractive hybridization products, Physiological Genomics, vol.22, issue.1, pp.99-107, 2005.
DOI : 10.1152/physiolgenomics.00276.2004

A. Khaliq, C. Dunk, J. Jiang, M. Shams, X. F. Li et al., Hypoxia down regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression : molecular evidence for « placental hyperoxia » in intrauterine growth restriction, Lab Invest, vol.2, pp.151-170, 1999.

S. E. Maynard, S. Venkatesha, R. Thadhani, and S. A. Karumanchi, Soluble Fms-like Tyrosine Kinase 1 and Endothelial Dysfunction in the Pathogenesis of Preeclampsia, Pediatric Research, vol.43, issue.5 Part 2, pp.1-7
DOI : 10.1203/01.PDR.0000159567.85157.B7

S. Venkatesha, M. Toporsian, C. Lam, J. Hanai, T. Mammoto et al., Soluble endoglin contributes to the pathogenesis of preeclampsia, Nature Medicine, vol.274, issue.6, pp.642-649, 2006.
DOI : 10.1038/nm1429

M. E. Chavarria, L. Lara-gonzalez, A. Gonzalez-gleason, I. Sojo, and A. Reyes, Maternal plasma cellular fibronectin concentrations in normal and preeclamptic pregnancies: A longitudinal study for early prediction of preeclampsia, American Journal of Obstetrics and Gynecology, vol.187, issue.3, pp.595-601, 2002.
DOI : 10.1067/mob.2002.123281

S. K. Nadar, A. Yemeni, E. Blann, A. D. Lip, and G. Y. , Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension, Thrombosis Research, vol.113, issue.2, pp.123-128, 2004.
DOI : 10.1016/j.thromres.2004.02.010

B. Isermann, R. Sood, and R. Pawlinski, The thrombomodulin???protein C system is essential for the maintenance of pregnancy, Nature Medicine, vol.9, issue.3, pp.331-338, 2003.
DOI : 10.1038/nm825

L. Giraud-sauveur, Thrombophilie biologique et récidive de pathologies vasculaires placentaires, pp.2008-89

G. Mello, E. Parretti, and L. Marozio, Thrombophilia Is Significantly Associated With Severe Preeclampsia: Results of a Large-Scale, Case-Controlled Study, Hypertension, vol.46, issue.6, pp.1270-1274, 2005.
DOI : 10.1161/01.HYP.0000188979.74172.4d

O. Burger, E. Pick, and J. Zwickel, Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies, Placenta, vol.25, issue.7, pp.608-622, 2004.
DOI : 10.1016/j.placenta.2003.12.009

M. Sammar, O. Sadan, and Z. Fleischfarb, Molecular and cellular impacts of placentarelated pathologies on PP13 in complicated premature deliveries, Am J Obstet Gynecol, p.77, 2005.

K. H. Nicolaides, R. Bindra, O. M. Turan, I. Chefetz, M. Sammar et al., A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound, Ultrasound in Obstetrics and Gynecology, vol.24, issue.1, pp.13-17, 2006.
DOI : 10.1002/uog.2686

R. Akolekar, A. Syngelaki, J. Beta, R. Kocylowski, and K. H. Nicolaides, Maternal serum placental protein 13 at 11??????13 weeks of gestation in preeclampsia, Prenatal Diagnosis, vol.453, issue.12, pp.1103-1108, 2009.
DOI : 10.1002/pd.2375

L. C. Poon, N. Maiz, C. Valencia, W. Plasencia, and K. H. Nicolaides, First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia, Ultrasound in Obstetrics and Gynecology, vol.86, issue.1, pp.23-33, 2009.
DOI : 10.1002/uog.6280

URL : https://kclpure.kcl.ac.uk/portal/en/publications/firsttrimester-maternal-serum-pregnancyassociated-plasma-proteina-and-preeclampsia(e7057d47-ac60-43ed-b2b3-f02ab0a490ba).html

J. K. Ranta, K. Raatikainen, and J. Romppanen, Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.157, issue.1, pp.48-52, 2011.
DOI : 10.1016/j.ejogrb.2011.03.004

R. Akolekar, E. Zaragoza, L. C. Poon, S. Pepes, and K. H. Nicolaides, Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia, Ultrasound in Obstetrics and Gynecology, vol.330, issue.6, pp.732-739, 2008.
DOI : 10.1002/uog.6244

S. Sifakis, R. Akolekar, D. Kappou, N. Mantas, and K. H. Nicolaides, Maternal serum insulin-like growth factor-I at 11-13 weeks in preeclampsia, Prenatal Diagnosis, vol.193, issue.11, pp.1026-1031, 2010.
DOI : 10.1002/pd.2555

S. Sifakis, R. Akolekar, D. Kappou, N. Mantas, and K. H. Nicolaides, Maternal serum insulinlike growth factor-binding protein-1 (IGFBP-1) at 11-13 weeks in pre-eclampsia, pp.196-201, 2011.

S. W. Wlash, J. E. Vaughan, Y. Wang, and I. J. Roberts, Placental isoprostane is significantly increased in preeclampsia, The FASEB Journal, vol.14, issue.10, pp.1289-1296, 2000.
DOI : 10.1096/fj.14.10.1289

A. Barden, L. Beilin, J. Ritchie, K. D. Croft, B. N. Walters et al., Plasma and Urinary 8-iso-Prostane as An Indicator of Lipid Peroxidation in Pre-Eclampsia and Normal Pregnancy, Clinical Science, vol.91, issue.6, pp.711-718, 1996.
DOI : 10.1042/cs0910711

S. Kharb, Total free radical trapping antioxidant potential in pre-eclampsia, International Journal of Gynecology & Obstetrics, vol.100, issue.4, pp.23-26, 2000.
DOI : 10.1016/S0020-7292(99)00198-8

B. Lorentzen and T. Henriksen, Plasma Lipids and Vascular Dysfunction in Preeclampsia, Seminars in Reproductive Medicine, vol.16, issue.01, pp.33-39, 1998.
DOI : 10.1055/s-2007-1016250

R. S. Bowen, Y. Zhang, Y. Gu, D. F. Lewis, and Y. Wang, Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia condition, Placenta, vol.26, issue.5, pp.402-409, 2005.
DOI : 10.1016/j.placenta.2004.07.007

S. Roberge, P. Villa, K. Nicolaides, Y. Giguère, M. Vainio et al., Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis, Fetal Diagnosis and Therapy, vol.31, issue.3, pp.141-146, 2012.
DOI : 10.1159/000336662

M. Toporsian, A Role for Endoglin in Coupling eNOS Activity and Regulating Vascular Tone Revealed in Hereditary Hemorrhagic Telangiectasia, Circulation Research, vol.96, issue.6, pp.684-692, 2005.
DOI : 10.1161/01.RES.0000159936.38601.22

S. Venkatesha, M. Toporsian, C. Lam, J. Hanai, T. Mammoto et al., Soluble endoglin contributes to the pathogenesis of preeclampsia, Nature Medicine, vol.274, issue.6, pp.642-649, 2006.
DOI : 10.1038/nm1429

F. Lebrin, M. Goumans, L. Jonker, R. Carvalho, G. Valdimarsdottir et al., Endoglin promotes endothelial cell proliferation and TGF-??/ALK1 signal transduction, The EMBO Journal, vol.14, issue.20, pp.4018-4028, 2004.
DOI : 10.1097/01.WCB.0000107730.66603.51

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC524335

C. Buhimschi, M. Baumbusch, A. Dulay, S. Lee, M. Wehrum et al., The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio, BJOG: An International Journal of Obstetrics & Gynaecology, vol.185, issue.3, pp.321-330, 2010.
DOI : 10.1111/j.1471-0528.2009.02434.x

P. Berson-loire, Prédiction de la pré-éclampsie : valeur des variables maternelles, du doppler artériel utérin et ombilical, et du dosage de sVEGFR et PlGF, pp.2009-55

R. Akolekar, J. De-cruz, J. Foidart, C. Munaut, and K. Nicolaides, Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia, Prenatal Diagnosis, vol.160, pp.191-197, 2010.
DOI : 10.1002/pd.2433

T. Nagamatsu, T. Fujii, and M. Kusumi, Cytotrophoblasts Up-Regulate Soluble Fms-Like Tyrosine Kinase-1 Expression under Reduced Oxygen: An Implication for the Placental Vascular Development and the Pathophysiology of Preeclampsia, Endocrinology, vol.145, issue.11, pp.4838-4845, 2004.
DOI : 10.1210/en.2004-0533

C. J. Lockwood, P. Toti, and F. Arcuri, Thrombin Regulates Soluble fms-Like Tyrosine Kinase-1 (sFlt-1) Expression in First Trimester Decidua, The American Journal of Pathology, vol.170, issue.4, pp.1398-1405, 2007.
DOI : 10.2353/ajpath.2007.060465

L. Anton, D. C. Merrill, L. A. Neves, C. Gruver, C. Moorefield et al., Angiotensin II and angiotensin-(1-7) decrease sFlt-1 release in normal but not preeclamptic chorionic villi : an in vitro study, Reproductive Biology and Endocrinology, vol.8, issue.135, p.10, 2010.

A. J. Buurma, M. E. Penning, F. Prins, J. M. Schutte, J. A. Brujin et al., Preeclampsia Is Associated With the Presence of Transcriptionally Active Placental Fragments in the Maternal Lung, Hypertension, vol.62, issue.3, pp.608-613, 2013.
DOI : 10.1161/HYPERTENSIONAHA.113.01505

D. S. Tannetta, R. A. Dragovic, C. Gardiner, C. W. Redman, and I. L. Sargent, Characterisation of Syncytiotrophoblast Vesicles in Normal Pregnancy and Pre-Eclampsia: Expression of Flt-1 and Endoglin, PLoS ONE, vol.Biomaterials, issue.29(12), p.56754, 2013.
DOI : 10.1371/journal.pone.0056754.t001

D. W. Tsui, K. C. Chan, S. S. Chim, L. W. Chan, T. Y. Leung et al., Quantitative aberrations of hypermethylatedRASSF1A gene sequences in maternal plasma in pre-eclampsia, Prenatal Diagnosis, vol.184, issue.13, pp.1212-1218, 2007.
DOI : 10.1002/pd.1897

M. L. Bellido, R. Radpour, O. Lapaire, I. De-bie, I. Hosli et al., MALDI-TOF Mass Array Analysis of RASSF1A and SERPINB5 Methylation Patterns in Human Placenta and Plasma1, Biology of Reproduction, vol.82, issue.4, pp.745-750, 2010.
DOI : 10.1095/biolreprod.109.082271

Z. Wang, S. Lu, C. Liu, B. Zhao, K. Pei et al., Expressional and epigenetic alterations of placental matrix metalloproteinase 9 in preeclampsia, Gynecological Endocrinology, vol.20, issue.2, pp.96-102, 2010.
DOI : 10.1016/S0167-4889(98)00020-2

G. Gascoin-lachambre, C. Buffat, R. Rebourcet, S. T. Chelbi, V. Rigourd et al., Cullins in Human Intra-Uterine Growth Restriction: Expressional and Epigenetic Alterations, Placenta, vol.31, issue.2, pp.151-157, 2010.
DOI : 10.1016/j.placenta.2009.11.008

S. T. Chelbi, F. Mondon, H. Jammes, C. Buffat, T. M. Mignot et al., Expressional and Epigenetic Alterations of Placental Serine Protease Inhibitors: SERPINA3 Is a Potential Marker of Preeclampsia, Hypertension, vol.49, issue.1, pp.76-83, 2007.
DOI : 10.1161/01.HYP.0000250831.52876.cb

R. Calicchio, C. Buffat, D. Vainam, and F. Miralles, Dysfonction endothéliale : rôle dans le syndrome maternel de la prééclampsie et conséquences à long terme pour le système cardiovasculaire, ANCAAN, mars 2013
DOI : 10.1016/j.ancard.2013.03.002

S. Sankaralingam, Y. Xu, T. Sawamura, and S. T. Davidge, Increased Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Expression in the Maternal Vasculature of Women With Preeclampsia: Role for Peroxynitrite, Hypertension, vol.53, issue.2, pp.270-277, 2009.
DOI : 10.1161/HYPERTENSIONAHA.108.122630

J. S. Gilbert, M. J. Ryan, B. Lamarca, M. Sedeck, S. R. Murphy et al., Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction, AJP: Heart and Circulatory Physiology, vol.294, issue.2, pp.541-550, 2008.
DOI : 10.1152/ajpheart.01113.2007

M. M. Faas, F. Spaans, D. Vos, and P. , Monocytes and macrophages in pregnancy and preeclampsia , Frontiers in immunology, pp.98-109

A. E. Wallace, R. Fraser, and J. E. Cartwright, Extravillous trophoblast and decidual natural killer cells: a remodelling partnership, Human Reproduction Update, vol.18, issue.4, pp.458-471, 2012.
DOI : 10.1093/humupd/dms015

J. Svensson-arvelund, J. Ernerudh, E. Buse, J. M. Cline, J. D. Haeger et al., The Placenta in Toxicology. Part II, Toxicologic Pathology, vol.69, issue.1, pp.327-338, 2014.
DOI : 10.1182/blood-2010-02-258558

S. Gordon and P. Taylor, Monocyte and macrophage heterogeneity, Nature Reviews Immunology, vol.33, issue.12, pp.953-64, 2005.
DOI : 10.1038/nri1733

A. Mantovani, S. K. Biswas, M. R. Galdiero, A. Sica, and M. Locati, Macrophage plasticity and polarization in tissue repair and remodelling, The Journal of Pathology, vol.224, issue.2, pp.176-185, 2013.
DOI : 10.1002/path.4133

A. M. Borzychowski, I. L. Sargent, and C. W. Redman, Inflammation and pre-eclampsia, Seminars in Fetal and Neonatal Medicine, vol.11, issue.5, pp.309-316, 2006.
DOI : 10.1016/j.siny.2006.04.001

J. R. Mellembakken, P. Aukrust, M. K. Olafsen, T. Ueland, K. Hestdal et al., Activation of Leukocytes During the Uteroplacental Passage in Preeclampsia, Hypertension, vol.39, issue.1, pp.155-160, 2002.
DOI : 10.1161/hy0102.100778

G. P. Sacks, K. Studena, I. L. Sargent, and C. W. Redman, Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis, American Journal of Obstetrics and Gynecology, vol.179, issue.1, pp.180-186, 1998.
DOI : 10.1016/S0002-9378(98)70254-6

M. T. Gervasi, T. Chaiworapongsa, P. Pacora, N. Naccasha, B. H. Yoon et al., Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia, American Journal of Obstetrics and Gynecology, vol.185, issue.4, pp.792-797, 2001.
DOI : 10.1067/mob.2001.117311

P. Luppi, H. Tse, K. Lain, N. Markovic, J. Piganelli et al., Preeclampsia Activates Circulating Immune Cells with Engagement of the NF-kappaB Pathway, American Journal of Reproductive Immunology, vol.10, issue.2, pp.135-144, 2006.
DOI : 10.1016/S0140-6736(99)08016-2

M. Sakai, H. Tsuda, K. Tanebe, Y. Sasaki, and S. Saito, Interleukin-12 Secretion by Peripheral Blood Mononuclear Cells is Decreased in Normal Pregnant Subjects and Increased in Preeclamptic Patients, American Journal of Reproductive Immunology, vol.87, issue.2, pp.91-97, 2002.
DOI : 10.1084/jem.181.2.537

J. Peraçoli, M. Rudge, and M. Peraçoli, Tumor Necrosis Factor-alpha in Gestation and Puerperium of Women with Gestational Hypertension and Pre-eclampsia, American Journal of Reproductive Immunology, vol.75, issue.3, pp.177-85, 2007.
DOI : 10.1034/j.1600-0412.1999.780803.x

A. Veenstra-van-nieuwenhoven, H. Moes, M. Heineman, J. Santema, and M. Faas, Cytokine Production by Monocytes, NK Cells, and Lymphocytes Is Different in Preeclamptic Patients as Compared with Normal Pregnant Women, Hypertension in Pregnancy, vol.55, issue.3, pp.207-224, 2008.
DOI : 10.1111/j.1471-0528.1998.tb10178.x

J. Brewster, N. Orsi, N. Gopichandran, U. Ekbote, E. Cadogan et al., Whole Blood Stimulation Model, Hypertension in Pregnancy, vol.101, issue.2, pp.1-16, 2008.
DOI : 10.1084/jem.20041214

G. Sacks, L. Clover, D. Bainbridge, C. Redman, and I. Sargent, Flow Cytometric Measurement of Intracellular Th1 and Th2 Cytokine Production by Human Villous and Extravillous Cytotrophoblast, Placenta, vol.22, issue.6, pp.550-559, 2001.
DOI : 10.1053/plac.2001.0686

C. Redman, D. Tannetta, R. Dragovic, C. Gardiner, J. Southcombe et al., Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia, Placenta, vol.33, pp.2012-2060
DOI : 10.1016/j.placenta.2011.12.006

D. Bianchi, G. Zickwolf, G. Weil, S. Sylvester, D. Maria et al., Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum., Proceedings of the National Academy of Sciences, vol.93, issue.2, pp.705-708, 1996.
DOI : 10.1073/pnas.93.2.705

M. Faas, M. Van-pampus, Z. Anninga, J. Salomons, I. Westra et al., Plasma from preeclamptic women activates endothelial cells via monocyte activation in vitro, Journal of Reproductive Immunology, vol.87, issue.1-2, pp.28-38, 2010.
DOI : 10.1016/j.jri.2010.07.005

Z. Pang and F. Xing, Comparative study on the expression of cytokine ??? receptor genes in normal and preeclamptic human placentas using DNA microarrays, Journal of Perinatal Medicine, vol.31, issue.2, pp.153-162, 2003.
DOI : 10.1515/JPM.2003.021

D. Benyo, A. Smarason, C. Redman, C. Sims, and K. Conrad, Expression of Inflammatory Cytokines in Placentas from Women with Preeclampsia, Journal of Clinical Endocrinology & Metabolism, vol.86, issue.6, pp.2505-2512, 2001.
DOI : 10.1210/jc.86.6.2505

Y. Wang and S. Walsh, TNF?? concentrations and mRNA expression are increased in preeclamptic placentas, Journal of Reproductive Immunology, vol.32, issue.2, pp.157-169, 1996.
DOI : 10.1016/S0165-0378(96)00998-9

A. Hennessy, H. Pilmore, L. Simmons, and D. Painter, A deficiency of placental IL-10 in preeclampsia, J Immunol, vol.163, issue.6, pp.3491-3495, 1999.

D. Rein, M. Breidenbach, B. Hönscheid, U. Friebe-hoffmann, H. Engel et al., Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro, Cytokine, vol.23, issue.4-5, pp.4-5, 2003.
DOI : 10.1016/S1043-4666(03)00220-5

M. Faas, G. Schuiling, J. Baller, C. Visscher, and W. Bakker, A new animal model for human preeclampsia: Ultra-lowdose endotoxin infusion in pregnant rats, American Journal of Obstetrics and Gynecology, vol.171, issue.1, pp.158-64, 1994.
DOI : 10.1016/0002-9378(94)90463-4

M. Faas, G. Van-der-schaaf, T. Borghuis, R. Jongman, M. Van-pampus et al., Extracellular ATP induces albuminuria in pregnant rats, Nephrology Dialysis Transplantation, vol.25, issue.8, pp.2468-2478, 2010.
DOI : 10.1093/ndt/gfq095

L. Marca, B. Speed, J. Fournier, L. Babcock, S. Berry et al., Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade, Hypertension, vol.52, issue.6, pp.1161-1167, 2008.

J. Bulmer, L. Morrison, M. Longfellow, A. Ritson, and D. Pace, Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies, Human Reproduction, vol.6, issue.6, pp.791-798, 1991.
DOI : 10.1093/oxfordjournals.humrep.a137430

L. Klentzeris, J. Bulmer, A. Warren, L. Morrison, T. Li et al., Endometrial lymphoid tissue in the timed endometrial biopsy: Morphometric and immunohistochemical aspects, American Journal of Obstetrics and Gynecology, vol.167, issue.3, pp.667-674, 1992.
DOI : 10.1016/S0002-9378(11)91568-3

J. Hunt, L. Miller, and J. Platt, Hormonal Regulation of Uterine Macrophages, Developmental Immunology, vol.6, issue.1-2, pp.1-2, 1998.
DOI : 10.1155/1998/87527

P. Williams, R. Searle, S. Robson, B. Innes, and J. Bulmer, Decidual leucocyte populations in early to late gestation normal human pregnancy, Journal of Reproductive Immunology, vol.82, issue.1, pp.24-31, 2009.
DOI : 10.1016/j.jri.2009.08.001

J. Bulmer, L. Morrison, and J. Smith, Expression of class II MHC gene products by macrophages in human uteroplacental tissue, Immunology, vol.63, issue.4, pp.707-714, 1988.

J. Bulmer and P. Johnson, Macrophage populations in the human placenta and amniochorion, Clin Exp Immunol, vol.57, issue.2, pp.393-403, 1984.

J. Bulmer, P. Williams, G. Lash, S. Smith, C. Dunk et al., Immune cells in the placental bed Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy Vascular-leukocyte interactions: mechanisms of human decidual spiral artery remodeling in vitro, Int J Dev Biol Am J Pathol Am J Pathol, vol.54, issue.177 2, pp.2-3, 2009.

V. Abrahams, Y. Kim, S. Straszewski, R. Romero, and G. Mor, Macrophages and Apoptotic Cell Clearance During Pregnancy, American Journal of Reproductive Immunology, vol.13, issue.4, pp.275-282, 2004.
DOI : 10.1038/75074

G. Laskarin, K. Cupurdija, V. Tokmadzic, D. Dorcic, J. Dupor et al., The presence of functional mannose receptor on macrophages at the maternal-fetal interface, Human Reproduction, vol.20, issue.4, pp.1057-1066, 2005.
DOI : 10.1093/humrep/deh740

J. Svensson, M. Jenmalm, A. Matussek, R. Geffers, G. Berg et al., Macrophages at the Fetal-Maternal Interface Express Markers of Alternative Activation and Are Induced by M-CSF and IL-10, The Journal of Immunology, vol.187, issue.7, pp.3671-3682, 2010.
DOI : 10.4049/jimmunol.1100130

B. Houser, T. Tilburgs, J. Hill, M. Nicotra, and J. Strominger, Two Unique Human Decidual Macrophage Populations, The Journal of Immunology, vol.186, issue.4, pp.2633-2642, 2011.
DOI : 10.4049/jimmunol.1003153

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712354

M. Petroff, P. Sedlmayr, D. Azzola, and J. Hunt, Decidual macrophages are potentially susceptible to inhibition by class Ia and class Ib HLA molecules, Journal of Reproductive Immunology, vol.56, issue.1-2, pp.1-2, 2002.
DOI : 10.1016/S0165-0378(02)00024-4

M. Hayashi, K. Hoshimoto, T. Ohkura, and N. Inaba, Increased Levels of Macrophage Colony-Stimulating Factor in the Placenta and Blood in Preeclampsia, American Journal of Reproductive Immunology, vol.4, issue.1, pp.19-24, 2002.
DOI : 10.1097/00000441-199804000-00007

H. Katabuchi, S. Yih, T. Ohba, K. Matsui, K. Takahashi et al., Characterization of macrophages in the decidual atherotic spiral artery with special reference to the cytology of foam cells, Medical Electron Microscopy, vol.36, issue.4, pp.253-262, 2003.
DOI : 10.1007/s00795-003-0223-2

F. Reister, H. Frank, W. Heyl, G. Kosanke, B. Huppertz et al., The Distribution of Macrophages in Spiral Arteries of the Placental Bed in Pre-eclampsia Differs from that in Healthy Patients, Placenta, vol.20, issue.2-3, pp.2-3, 1999.
DOI : 10.1053/plac.1998.0373

M. Haeger, M. Unander, B. Norder-hansson, M. Tylman, A. Bengtsson et al., Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors Altered expression of immune-associated genes in first-trimester human decidua of pregnancies later complicated with hypertension or foetal growth restriction, Obstet Gynecol J Reprod Immunol Placenta, vol.79, issue.5, pp.19-26, 1992.

C. Helige, H. Ahammer, A. Hammer, B. Huppertz, H. Frank et al., Trophoblastic invasion in vitro and in vivo: similarities and differences, Human Reproduction, vol.23, issue.10, pp.2282-2291, 2008.
DOI : 10.1093/humrep/den198

S. Renaud, L. Postovit, S. Macdonald-goodfellow, G. Mcdonald, J. Caldwell et al., Activated Macrophages Inhibit Human Cytotrophoblast Invasiveness In Vitro1, Biology of Reproduction, vol.73, issue.2, pp.237-243, 2005.
DOI : 10.1095/biolreprod.104.038000

S. Renaud, S. Macdonald-goodfellow, and C. Graham, Coordinated regulation of human trophoblast invasiveness by macrophages and interleukin 10, Biol Reprod, vol.63, issue.3, pp.448-454, 2007.

I. A. Greer, N. G. Haddad, J. Dawes, F. D. Johnstone, and A. A. Calder, Neutrophil activation in pregnancy-induced hypertension, BJOG: An International Journal of Obstetrics and Gynaecology, vol.59, issue.8, pp.978-982, 1989.
DOI : 10.1002/path.1700930219

A. Barden, D. Graham, L. J. Beilin, J. Ritchie, R. Baker et al., Neutrophil CD11B Expression and Neutrophil Activation in Pre-Eclampsia, Clinical Science, vol.92, issue.1, pp.37-44, 1997.
DOI : 10.1042/cs0920037

B. Haddad, . Louis-sylvestre, and B. Paniel, Inflammation maternelle et prééclampsie, J Gynecol Obstet Biol Reprod, vol.30, pp.17-20, 2001.

D. I. Santoso, R. Rogers, E. M. Wallace, U. Manuelpillai, S. B. Subakir et al., Localization of Indoleamine 2,3-Dioxygenase and 4-Hydroxynonenal in Normal and Pre-eclamptic Placentae, Placenta The STOX1 genotype associated with pre-eclampsia eads to a reduction of trophoblast invasion by alpha-T-catenin upregulation, Hum Mol Genet, vol.23, issue.13, pp.373-379, 2002.

M. Vilotte, J. Castille, M. Breuiller-fouché, N. Danial, F. Le-provost et al., Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment, Hypertension, vol.61, pp.662-668, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01019878

L. Doridot, Overexpression of STOX1 in the feto-placental unit leads to an altered placental function, accompanied with fetal overgrowth ? Article en préparation, pp.2013-2036

L. Doridot, Zinc Finger Transcription Factors are deregulated in placental diseases ? Article en préparation ? Université Paris Descartes, pp.2013-2042

R. Akolekar, E. Zaragoza, L. C. Poon, S. Pepes, and K. H. Nicolaides, Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia, Ultrasound in Obstetrics and Gynecology, vol.330, issue.6, pp.732-739, 2008.
DOI : 10.1002/uog.6244

L. C. Poon, N. Maiz, C. Valencia, W. Plasencia, and K. H. Nicolaides, First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia, Ultrasound in Obstetrics and Gynecology, vol.86, issue.1, pp.23-33, 2009.
DOI : 10.1002/uog.6280

URL : https://kclpure.kcl.ac.uk/portal/en/publications/firsttrimester-maternal-serum-pregnancyassociated-plasma-proteina-and-preeclampsia(e7057d47-ac60-43ed-b2b3-f02ab0a490ba).html

J. Foidart, C. Munaut, F. Chantraine, R. Akolekar, and K. H. Nicolaides, Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia, Ultrasound in Obstetrics and Gynecology, vol.182, pp.680-387, 2010.
DOI : 10.1002/uog.7621

J. Lai, A. Syngelaki, L. C. Poon, M. Nucci, and K. H. Nicolaides, Maternal serum soluble endoglin at 30-33 weeks in the prediction of preeclampsia, Fetal Diagn, pp.149-155, 2013.

R. O. Bahado-singh, R. Akolekar, and R. Mandal, First-trimester metabolomic detection of late-onset preeclampsia, American Journal of Obstetrics and Gynecology, vol.208, issue.1, pp.1-7, 2013.
DOI : 10.1016/j.ajog.2012.11.003

K. Spencer, N. J. Cowans, and K. H. Nicolaides, Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia, Ultrasound in Obstetrics and Gynecology, vol.15, issue.5, pp.622-626, 2008.
DOI : 10.1002/uog.6212

J. Lai, A. Pinas, L. C. Poon, M. Agathokleous, and K. H. Nicolaides, Maternal serum placental growth factor, pregnancy-associated plasma protein-A and free ?-Human Chorionic Gonadotrophin at 30-33 weeks in the prediction of pre-eclampsia, Fetal Diagn, pp.164-172, 2013.

V. H. Shore, T. H. Wang, C. L. Wang, R. J. Torry, M. R. Caudle et al., Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast, Placenta, vol.18, issue.8, pp.657-665, 1997.
DOI : 10.1016/S0143-4004(97)90007-2

J. A. Lykke, J. Langhoff-roos, B. M. Sibai, E. F. Funai, E. W. Triche et al., Hypertensive Pregnancy Disorders and Subsequent Cardiovascular Morbidity and Type 2 Diabetes Mellitus in the Mother, Hypertension, vol.53, issue.6, pp.944-951, 2009.
DOI : 10.1161/HYPERTENSIONAHA.109.130765

C. Jeanne-pasquier, Affections maternelles compliquant la grossesse : examen placentaire ? Journée d'enseignement interrégional, pp.2-2012

E. Clouqueur, D. Subtil, G. Robin, and V. Tsatsaris, Que reste-t-il des indications de l'aspirine en cours de grossesse ?, J Gynecol Obstet Biol Reprod, vol.391, issue.1, 2010.